Research has shown that low-dose azithromycin is effective in managing bronchiectasis without NTM, with promising results. However, a potential drawback is that azithromycin is a key antibiotic for treating NTM. If resistance develops, it can no longer be used for NTM treatment, making management more challenging. Consulting a pulmonary specialist with expertise in bronchiectasis and NTM disease can you make this decision.